New research could lead to swabs that detect how healthy a wound is.
Researchers say we could prevent the vast majority of new HIV infections tomorrow by improving the health of people living with HIV today.
Pharmaceutical company AbbVie has deeply discounted their new drug Viekira Pak, the first three-in-one treatment chronic hepatitis C in those living with HIV.
One of the goals of HIV service providers is to connect patients with care as quickly as possible, especially since early treatment has been shown to provide long-term advantages. But a new French study reports that any immune recovery benefits gained by starting antiretroviral medications may be lost if treatment is later interrupted.
The pharmaceutical company Merck’s new HIV drug, doravirine, worked so well in patients new to treatment that it moved to Phase III clinical trials — the last stage before drug approval — at the end of last year.
Vaccinations and a 24/7 chat are just a few of the comprehensive services offered at the pharmacy chain.